MTVA
MTVA
NASDAQ · Biotechnology

Metavia Inc

$1.67
+0.01 (+0.60%)
As of Sep 28, 10:45 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +376.0% upside
Low Target $5.82
Average Target $7.95
High Target $9.13
Current Price $1.67
Current
$1.67
Target
$7.95
$5.82 $7.95 avg $9.13
Scenario Analysis
Bear Case
$5.82
248.5%
Low target
Base Case
$7.95
+376.0%
Avg target
Bull Case
$9.13
+446.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$14.85
-88.8% from high
52-Week Low
$0.97
+72.9% from low
Target vs 52W High
$7.95
-46.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%